{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T14:16:45Z","timestamp":1791037005165,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2004,2]]},"DOI":"10.1016\/j.ejca.2003.09.016","type":"journal-article","created":{"date-parts":[[2003,11,7]],"date-time":"2003-11-07T14:21:42Z","timestamp":1068214902000},"page":"422-428","source":"Crossref","is-referenced-by-count":77,"title":["One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations"],"prefix":"10.1016","volume":"40","author":[{"given":"S.","family":"Malander","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ridderheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"M\u00e5sb\u00e4ck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Loman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Kristoffersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Olsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Nilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c5.","family":"Borg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2003.09.016_BIB1","unstructured":"Parkin D.M. Muir C.S. Cancer Incidence in Five Continents. Comparability and Quality of Data. Scientific Publication No. 120 Geneva, IARC 1992, 45\u2013173 (http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve &db=PubMed&dopt=Citation&list_uids=93259654 eng)."},{"key":"10.1016\/j.ejca.2003.09.016_BIB2","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/(SICI)1097-0215(19990924)83:1<18::AID-IJC5>3.0.CO;2-M","article-title":"Estimates of the worldwide mortality from 25 cancers in 1990","volume":"83","author":"Pisani","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2003.09.016_BIB3","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1006\/gyno.1996.4572","article-title":"Hereditary ovarian cancer","volume":"64","author":"Boyd","year":"1997","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ejca.2003.09.016_BIB4","unstructured":"Cancer Incidence in Sweden 2000 (http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&dopt =Citation&list_uids=Id string.).The National Board of Health and Welfare, Cancer Incidence in Sweden, 2000 (www.sos.se)."},{"key":"10.1016\/j.ejca.2003.09.016_BIB5","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1001\/archinte.1995.00430090034005","article-title":"The impact of family history on ovarian cancer risk. The Utah Population Database","volume":"155","author":"Kerber","year":"1995","journal-title":"Arch Intern. Med."},{"key":"10.1016\/j.ejca.2003.09.016_BIB6","first-page":"103","article-title":"Cancer risk estimates for family members of a population-based family registry for breast and ovarian cancer","volume":"9","author":"Ziogas","year":"2000","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.ejca.2003.09.016_BIB7","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1001\/jama.283.17.2260","article-title":"Clinicopathologic features of BRCA-linked and sporadic ovarian cancer","volume":"283","author":"Boyd","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.ejca.2003.09.016_BIB8","first-page":"3144","article-title":"Mutational analysis of BRCA1 and BRCA2 and clinicopathologic analysis of ovarian cancer in 82 ovarian cancer families","volume":"7","author":"Sekine","year":"2001","journal-title":"Clin. Canc.er Res."},{"key":"10.1016\/j.ejca.2003.09.016_BIB9","doi-asserted-by":"crossref","unstructured":"Watson P., Butzow R., Lynch HT. et al. The clinical features of ovarian cancer in hereditary nonpolyposis colorectal cancer. Gynecol Oncol 2001 82, 223\u2013228 (http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation &list_uids=21423688 eng).","DOI":"10.1006\/gyno.2001.6279"},{"key":"10.1016\/j.ejca.2003.09.016_BIB10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1006\/gyno.2001.6465","article-title":"Hereditary ovarian cancer. Lessons from the first twenty years of the Gilda Radner Familial Ovarian Cancer Registry","volume":"85","author":"Piver","year":"2002","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ejca.2003.09.016_BIB11","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S0002-9378(98)70476-4","article-title":"BRCA1, BRCA2, and hereditary nonpolyposis colorectal cancer gene mutations in an unselected ovarian cancer population","volume":"178","author":"Rubin","year":"1998","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ejca.2003.09.016_BIB12","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/ng0396-333","article-title":"The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds","volume":"12","author":"Tavtigian","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejca.2003.09.016_BIB13","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1200\/JCO.2001.19.8.2247","article-title":"Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluation clinic","volume":"19","author":"Martin","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejca.2003.09.016_BIB14","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1086\/318787","article-title":"Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer","volume":"68","author":"Risch","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ejca.2003.09.016_BIB15","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","volume":"72","author":"Antioniou","year":"2003","journal-title":"Am J Human Genet"},{"key":"10.1016\/j.ejca.2003.09.016_BIB16","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0092-8674(02)00615-3","article-title":"Cancer susceptibility and the functions of BRCA1 and BRCA2","volume":"108","author":"venkitaraman","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.ejca.2003.09.016_BIB17","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1046\/j.1525-1438.2000.010004289.x","article-title":"BRCA1 and BRCA2 mutations in ovarian cancer","volume":"10","author":"Koul","year":"2000","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ejca.2003.09.016_BIB18","first-page":"1068","article-title":"Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandinavian familial breast cancer","volume":"60","author":"Hakansson","year":"1997","journal-title":"Am. J. Hum Genet."},{"key":"10.1016\/j.ejca.2003.09.016_BIB19","first-page":"1367","article-title":"BRCA2 germ-line mutations are frequent in male breast cancer patients without a family history of the disease","volume":"58","author":"Haraldsson","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejca.2003.09.016_BIB20","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1006\/geno.1999.6026","article-title":"Denaturing high-performance liquid chromatography detects reliably BRCA1 and BRCA2 mutations","volume":"62","author":"Wagner","year":"1999","journal-title":"Genomics"},{"key":"10.1016\/j.ejca.2003.09.016_BIB21","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/hmg\/10.4.353","article-title":"Functional analysis of BRCA1 C-terminal missense mutations identified in breast and ovarian cancer families","volume":"10","author":"Vallon-Christersson","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ejca.2003.09.016_BIB22","doi-asserted-by":"crossref","first-page":"497","DOI":"10.4161\/cbt.1.5.164","article-title":"A Naturally occurring allele of BRCA1 coding for a temperature-sensitive mutant protein","volume":"1","author":"Worley","year":"2002","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.ejca.2003.09.016_BIB23","unstructured":"Breast cancer information core (http:\/\/research.nhgri.nih.gov\/bic\/ ) (http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation &list_uids=Id string)."},{"key":"10.1016\/j.ejca.2003.09.016_BIB24","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1038\/sj.onc.1202003","article-title":"The BRCA2 is a histone acetyltransferase","volume":"16","author":"Siddique","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.ejca.2003.09.016_BIB25","first-page":"1531","article-title":"Potential role of BRCA2 in a mitotic checkpoint after phosphorylation by hBUBR1","volume":"60","author":"Futamura","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejca.2003.09.016_BIB26","first-page":"2998","article-title":"Mutation analysis of the BRCA1 gene in ovarian cancers","volume":"55","author":"Takahashi","year":"1995","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejca.2003.09.016_BIB27","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1056\/NEJM199704173361602","article-title":"Contribution of BRCA1 mutations to ovarian cancer","volume":"336","author":"Stratton","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejca.2003.09.016_BIB28","first-page":"2433","article-title":"Frequency of germline and somatic BRCA1 mutations in ovarian cancer","volume":"4","author":"Berchuck","year":"1998","journal-title":"Clin. Cancer. Res."},{"key":"10.1016\/j.ejca.2003.09.016_BIB29","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJM200107263450401","article-title":"Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation","volume":"345","author":"Modan","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejca.2003.09.016_BIB30","first-page":"2738","article-title":"Mutations of the BRCA2 gene in ovarian carcinomas","volume":"56","author":"Takahashi","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejca.2003.09.016_BIB31","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1086\/302671","article-title":"The genetic epidemiology of early-onset epithelial ovarian cancer","volume":"65","author":"Stratton","year":"1999","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ejca.2003.09.016_BIB32","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1086\/318181","article-title":"Variation in cancer risks, by mutation position, in BRCA2 mutation carriers","volume":"68","author":"Thompson","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ejca.2003.09.016_BIB33","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJM199611073351901","article-title":"Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1","volume":"335","author":"Rubin","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejca.2003.09.016_BIB34","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1200\/JCO.20.2.463","article-title":"Effect of BRCA mutations on the length of survival in epithelial ovarian tumors","volume":"20","author":"Ben David","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejca.2003.09.016_BIB35","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0301-2115(01)00318-9","article-title":"Survival analysis in familial ovarian cancer, a case control study","volume":"98","author":"Zweemer","year":"2001","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.ejca.2003.09.016_BIB36","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1200\/JCO.1998.16.2.397","article-title":"Survival of BRCA1 breast and ovarian cancer patients","volume":"16","author":"Johannsson","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejca.2003.09.016_BIB37","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/S0046-8177(00)80014-3","article-title":"Histopathology of familial ovarian tumors in women from families with and without germline BRCA1 mutations","volume":"31","author":"Werness","year":"2000","journal-title":"Hum. Pathol."}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804903008116?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804903008116?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,17]],"date-time":"2019-02-17T08:52:13Z","timestamp":1550393533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804903008116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["S0959804903008116"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2003.09.016","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2004,2]]}}}